[1]
A. Ansari Djafari, “Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Guerin for the Treatment of Intermediate-Risk Non-Muscle Invasive Bladder Cancer: A Randomized Controlled Trial”, Urol J, vol. 20, no. 02, pp. 123–128, Feb. 2023.